Hong Kong, China

Wai Lun Man

This inventor holds 1 USPTO granted patent. Top assignees: City University of Hong Kong, Versitech, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wai Lun Man. Retrieved from https://idiyas.com/inventor/wai-lun-man

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wai Lun Man: Innovator in Cancer Treatment

Introduction

Wai Lun Man is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the creation of nitridoosmium complexes, which have potential applications in oncology.

Latest Patents

Wai Lun Man holds a patent for "Nitridoosmium(VI) complexes for treatment of cancer." This invention relates to nitridoosmium complexes and methods of using these compounds as treatments for cancer. His research aims to provide new therapeutic options for patients battling this disease.

Career Highlights

Throughout his career, Wai Lun Man has been associated with prestigious institutions such as the City University of Hong Kong and Versitech, Inc. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Wai Lun Man has worked alongside talented individuals, including Tai Chu Lau and Yun Wah Lam. These collaborations have contributed to the development of his innovative ideas and the successful execution of his research projects.

Conclusion

Wai Lun Man is a dedicated inventor whose work in cancer treatment showcases the potential of nitridoosmium complexes. His contributions to the field highlight the importance of innovation in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…